BGB-290-302 ChiCTR1800014643

Active, not recruiting

Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer

Beigene Study ID info

BGB-290-302 ChiCTR1800014643

ClinicalTrials.gov ID info

China Drug Trials ID info

CTR20171666

Study Overview

Sex: Female

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents

Study Overview

Sex: Female

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents